Large-scale testing (Phase 3)Study completedNCT04713592
What this trial is testing
Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement
Who this might be right for
Psoriasis
AbbVie 174